Endocrinology Test
|
|
| 1. Aldosterone release is responsible for: |
|
|
| 2. The GH systemic effect is mediated by: |
|
|
| 3. The confirmatory marker of Graves’ disease is: |
|
|
| 4. Which from the following statements regarding calcitonin is true: |
|
|
| 5. Zona glomerulosa: |
|
|
| 6. The endocrine complications of corticotherapy are: |
|
|
| 7. Differential diagnostic of gigantism has to be made with: |
|
|
| 8. The following are true regarding diagnostic of renal diabetes insipidus: |
|
|
| 9. The treatment of chronic parathyroid insufficiency consists of: |
|
|
| 10. Characteristics of asymptomatic hyperparathyroidism are: |
|
|
| 11. History with increased risk for thyroid cancer is presence in cases of: |
|
|
| 12. The peak bone mass is dependent on: |
|
|
| 13. The following are true about thyroid supplemental therapy: |
|
|
| 14. The following are true regarding nodular thyroid disease: |
|
|
| 15. The differential diagnosis of endogenous hypercorticism includes: |
|
|
| 16. The laboratory and paraclinical evaluation in parathyroid insufficiency show: |
|
|
| 17. Laboratory tests for positive diagnosis in pheocromocytoma can reveal: |
|
|
| 18. A prolactinoma can induce in women: |
|
|
| 19. Primary adrenal insufficiency appears in conditions of: |
|
|
| 20. The etiology of pituitary insufficiency includes: |
|
|
| 21. Lab exam in Cushing’s shows: |
|
|
| 22. Superior localization test for pheocromocytoma are: |
|
|
| 23. Adverse effects of the contraceptives are: |
|
|
| 24. Parathyroid localization evaluation: |
|
|
| 25. Which of the following statements regarding corticotropin-releasing hormone are true: |
|